Delivery Order SPE2DE24D0013-SPE2D625F8HN8
- Not listed
- The Defense Logistics Agency, through its Medical Supply Chain organization, awarded a delivery order valued at $1,277.84 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on July 21, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The delivery order represents a continuation of Cepheid's established relationship with federal defense and healthcare agencies as...
- The Defense or Civilian agency within Medical Supply Chain awarded a $5,775 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on July 22, 2025, with an ultimate completion date of July 29, 2025. This contract, identified as XPRSARS-COV2-10, involves delivery of molecular diagnostic solutions to the Sunnyvale, California location. The award carries no set-aside designation and represents a delivery order against one of Cepheid's existing Indefinite Delivery Vehicle contracts...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $20.4K to Cepheid Inc. on July 25, 2025, for molecular diagnostic solutions. Designated as Contract Number 4568895371 with the identifier XPCOV2/FLU/RSV-10, this firm fixed-price delivery order is set to be completed by August 1, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The contract involves diagnostics testing solutions, specifically targeting...
- The Defense Department's Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on July 18, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as XPCOV2/FLU/RSV-10, represents a delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation. Work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- The Defense Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic manufacturer headquartered in Sunnyvale, California, on July 21, 2025, with an ultimate completion date of July 28, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, carries no set-aside designation and pertains to COVID-19, influenza, and respiratory syncytial virus diagnostic solutions. The contract represents work performed under Cepheid's existing indefinite...
- Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, received a $6.8K delivery order from the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, for the KIT XPERT XPRESS COVID-19/FLU/RSV + Molecular Biology diagnostic kit. This firm fixed-price delivery order, with performance completion targeted for July 29, 2025, carries no set-aside designation and represents part of Cepheid's ongoing supply of molecular diagnostic testing solutions to...
- This delivery order, valued at $13.6K, was awarded on July 21, 2025, to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, by the Medical Supply Chain within the Department of Defense. The contract, which carries no set-aside designation and employs firm fixed-price terms, is scheduled for completion by July 28, 2025. Based on the contract nomenclature (XPCOV2/FLU/RSV-10), this delivery order pertains to diagnostic testing for COVID-19, influenza, and...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $2,471.70 by the Defense Department's Medical Supply Chain organization on July 18, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order carries no set-aside designation and represents procurement of diagnostic equipment, reagents, or testing services from Cepheid's core product portfolio, which includes GeneXpert...
- This delivery order, awarded on July 24, 2025, represents a $17,680 firm fixed-price contract between the Defense Logistics Agency's Medical Supply Chain division and Cepheid Inc. for a COVID-19/Influenza/RSV diagnostic kit containing 10 viral tests. The contract is set to be completed by July 31, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This award is issued without a set-aside designation and falls under Cepheid's existing indefinite delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a $27.2K firm fixed-price delivery order to Cepheid Inc. for the KIT XPERT XPRESS COVID-19, Influenza, and RSV molecular diagnostic kit on July 23, 2025, with completion targeted for July 25, 2025. The contract, which carries no set-aside designation, will be performed at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a continuation of Cepheid's established role as a primary supplier of molecular...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F8HN8Delivery Order
The Defense Logistics Agency's Medical Supply Chain division awarded a $5,174.64 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, has an ultimate completion date of July 30, 2025, and carries no set-aside designation. The contract references diagnostic testing for COVID-19, influenza, and respiratory syncytial virus (RSV), consistent with Cepheid's core product offerings of GeneXpert diagnostic systems and associated molecular reagents and test kits designed for infectious disease detection. This delivery order likely derives from one of Cepheid's existing indefinite delivery vehicles with the Department of Veterans Affairs, which total over $35 million and provide molecular diagnostic testing solutions across federal healthcare systems. Cepheid maintains strong positioning within the federal diagnostics market, with extensive experience delivering PCR testing systems, reagents, and assays to the VA's Veterans Integrated Service Networks and Defense Health Agency for conditions including COVID-19, influenza, RSV, and other infectious diseases. The relatively modest ceiling value reflects the delivery order structure typical of ongoing procurement under larger federal contract vehicles supporting federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 7/23/25 |